Milad Shirvaliloo

Dr. Milad Shirvaliloo is an Iranian physician-researcher with a strong interest in epigenetics, particularly the posttranslational modifications of histone proteins. He holds an MD degree from Tabriz University of Medical Sciences (2023) and maintains active research interests in epigenetics and bioinformatics, with a focus on lung cancer and respiratory infectious diseases. He serves on the Editorial Board of Epigenomics (since 2022) and holds an invited position as a Board Member for Molecular and Cellular Biochemistry. His work integrates clinical perspective with research, and he is committed to authoritative science communication.